Home > Insider Trading > Filing (0000899243-16-019192)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1512762	Coherus Biosciences Inc.	CHRS	Biological Products, (No Disgnostic Substances) (2836)	273615821

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1622139	K. Peter Watler	Coherus Biosciences, Inc. 333 Twin Dolphin Drive, Suite 600 Redwood City CA 94065	Chief Technical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2015-11-20	20,000	$1.42	20,000	No	4	M	Indirect	By Wife
Common Stock, $0.0001 Par Value	Disposition	2015-11-20	20,000	$27.41	0	No	4	S	Indirect	By Wife
Common Stock, $0.0001 Par Value	Acquisiton	2016-05-02	1,493	$2.08	1,493	No	4	M	Indirect	By Wife
Common Stock, $0.0001 Par Value	Disposition	2016-05-02	1,493	$20.00	0	No	4	S	Indirect	By Wife

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	By Wife
No	4	S	Indirect	By Wife
No	4	M	Indirect	By Wife
No	4	S	Indirect	By Wife

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-11-20	20,000	$0.00	20,000	$1.42
Common Stock	Stock Option (right to buy)	Disposition	2016-05-02	1,493	$0.00	1,493	$2.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,988		2023-11-21	No	4	M	Indirect
55,495		2023-02-27	No	4	M	Indirect

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person's wife.
A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from July 30, 2013, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from June 4, 2012, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date